Home » Topics » generic drugs

Senate considers ending Pharma pay-for-delay deals

US senators are introducing legislation to end pay-off deals that keep generic drugs off shelves and give pharmaceutical giants market exclusivity that costs consumers billions of dollars per year. The bid follows Thursday’s release of a Federal Trade Commission report documenting a significant rise in the number of so-called “pay-for-delay”…

Supreme Court to take up generic drug case

The US Supreme Court has decided to take up a case over whether pharmaceutical companies can pay makers of generic drugs to delay release of out of patent drugs. The case centers on the maker of a hormonal treatment called Androgel by Solvay, which is owned by US drug maker…

New legislation aims to curb cancer drug shortages

CHICAGO — A critical shortage of generic drugs in the United States, particularly in cancer care, could be curbed with legislation now being hammered out by the US House and Senate, doctors said on Monday. Similar versions have passed each chamber and may be reconciled in time for President Barack…